Clinical Trials Browser

Phase 3 × Rivaroxaban × 1 year × Clear all

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Phase 3 Not yet recruiting

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

Phase 3 Recruiting

Classical hematology

Neoplasms, Venous Thromboembolism